N-Methyl-beta-oxy-beta-phenylisopropylaminhydrochlorid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 10 USDMF, 4 CEP/COS, 2 JDMF, 2 EU WC, 17 KDMF, 4 NDC API, 3 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

13 FDF Dossiers, 4 FDA Orange Book, 3 Europe, 1 Canada, 1 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 23.5MG/5ML (4.7MG/ML), SOLUTION;INTRAVENOUS - 47MG/10ML (4.7MG/ML), SOLUTION;INTRAVENOUS - 47MG/ML (47MG/ML), SOLUTION;INTRAVENOUS - 47MG/5ML (9.4MG/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 5 SPI Pharma, 1 DKSH, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 12 BASF, 1 Bioplus Life Sciences, 4 DFE Pharma, 1 Finar, 5 Gangwal Chemicals, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 4 Kerry, 3 Keval Exports, 10 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 25 Roquette, 1 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 4 Silverline Chemicals, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

48 Fillers, Diluents & Binders, 26 Disintegrants & Superdisintegrants, 18 Direct Compression, 16 Granulation, 15 Thickeners and Stabilizers, 15 Lubricants & Glidants, 15 Co-Processed Excipients, 11 Solubilizers, 9 Taste Masking, 8 Coating Systems & Additives, 8 Film Formers & Plasticizers, 7 Controlled & Modified Release, 5 Chewable & Orodispersible Aids, 4 Topical, 4 Emulsifying Agents, 3 Parenteral, 2 API Stability Enhancers, 2 Rheology Modifiers